Xenetic Biosciences Inc. (XBIO)
NASDAQ: XBIO
· Real-Time Price · USD
3.23
0.49 (17.88%)
At close: Jun 24, 2025, 3:59 PM
3.20
-0.93%
After-hours: Jun 24, 2025, 06:19 PM EDT
17.88% (1D)
| Bid | 2.98 |
| Market Cap | 4.98M |
| Revenue (ttm) | 2.58M |
| Net Income (ttm) | -3.67M |
| EPS (ttm) | -2.38 |
| PE Ratio (ttm) | -1.36 |
| Forward PE | -0.62 |
| Analyst | n/a |
| Ask | 3.3 |
| Volume | 325,139 |
| Avg. Volume (20D) | 10,746 |
| Open | 3.28 |
| Previous Close | 2.74 |
| Day's Range | 2.66 - 3.35 |
| 52-Week Range | 2.20 - 5.20 |
| Beta | 2.29 |
About XBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XBIO
Website n/a
Next Earnings Release
Xenetic Biosciences Inc. is scheduled to release its earnings on Aug 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago · accessnewswire.com
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment- Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer (S...
